Skip to content
Home / Companies / RCUS RCU
Arcus Biosciences, Inc. (RCUS) XNYS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest RCUS Insider Trades
About Arcus Biosciences, Inc. (RCUS) Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Headquarters HAYWARD, CA
Employees 601
Listed 2018
Exchange XNYS https://www.arcusbio.com SEC filings for RCUS on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 9 105,389 $3.06M Grant or award 14 158,200 Option exercise 4 73,834
RCUS Insider Transactions (Form 4) 61 46 Form 4 filings on record, the earliest from Dec 4, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 21, 2026 AA Alexander Azoy - Officer Option exercise Common Stock 2,827
Recent RCUS Form 8-K Filings 5
Recent RCUS Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 21, 2026 ALEXANDER AZOY Officer 2,827 $83K View on EDGAR Jul 9, 2026 - -
RCUS Insider Trading - FAQ
What is the latest insider trade for RCUS? Arcus Biosciences, Inc. (RCUS) had 12 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for RCUS runs to 46 Form 4 filings, the earliest from 2024-12-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying RCUS stock? No insider purchases of RCUS were filed in the last 90 days.
How many insiders are selling RCUS stock? 9 insider sales of RCUS were filed in the last 90 days, totaling $3.06M.
Where can I see RCUS SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks RCUS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow RCUS insider buys? Create a free InsiderAlpha account and press Watch on this page to add RCUS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track RCUS insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Jul 9, 2026
Market cap $3.72B
P/E ratio -
Dividend yield -
Average volume 1.30M
52 week high $31.74
52 week low $10.40
Today's high $30.44
Today's low $29.06
Open $30.13
Volume 1.09M
Previous close $30.59
Shares outstanding 127.33M Market cap
$3.72B
601 employees
RCUS Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 9 sales totaling $3.06M.
Most-Active RCUS Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 21, 2026 AA Alexander Azoy - Officer Open-market sale Common Stock 2,827 $30.00 $85K
Aug 21, 2026 AA Alexander Azoy - Officer Option exercise Stock Option (right to buy) 2,827 $0.00 -
Jul 9, 2026 JJ Juan C. Jaen - Officer Open-market sale Common Stock 48,502 $30.05 $1.46M
Jul 10, 2026 JJ Juan C. Jaen - Officer Open-market sale Common Stock 19,799 $28.61 $566K
Jul 10, 2026 JJ Juan C. Jaen - Officer Open-market sale Common Stock 268 $29.40 $8K
Jun 22, 2026 JJ Juan C. Jaen - Officer Open-market sale Common Stock 9,236 $27.03 $250K
Jun 23, 2026 JJ Juan C. Jaen - Officer Open-market sale Common Stock 14,067 $27.69 $389K
Jun 23, 2026 JJ Juan C. Jaen - Officer Open-market sale Common Stock 1,697 $28.06 $48K
Jun 24, 2026 JJ Juan C. Jaen - Officer Open-market sale Common Stock 6,431 $29.66 $191K
Jun 11, 2026 NL Nicole Lambert - Director Grant or award Common Stock 5,700 $0.00 -
Jun 11, 2026 NL Nicole Lambert - Director Grant or award Stock Option (Right to Buy) 16,900 $0.00 -
Jun 11, 2026 PM Patrick Machado - Director Grant or award Stock Option (Right to Buy) 16,900 $0.00 -
Jun 11, 2026 PM Patrick Machado - Director Grant or award Common Stock 5,700 $0.00 -
Jun 11, 2026 YK Yasunori Kaneko - Director Grant or award Stock Option (Right to Buy) 16,900 $0.00 -
Jun 11, 2026 YK Yasunori Kaneko - Director Grant or award Common Stock 5,700 $0.00 -
Jun 11, 2026 CT Carolyn C. Tang - Officer Option exercise Common Stock 34,090 $2.57 $88K
Jun 11, 2026 CT Carolyn C. Tang - Officer Option exercise Stock Option (Right to Buy) 34,090 $2.57 $88K
Jun 11, 2026 DL David L. Lacey - Director Grant or award Stock Option (Right to Buy) 16,900 $0.00 -
Jun 11, 2026 DL David L. Lacey - Director Grant or award Common Stock 5,700 $0.00 -
Jun 11, 2026 KF Kathryn E. Falberg - Director Grant or award Stock Option (Right to Buy) 16,900 $0.00 -
Jun 11, 2026 AR Antoni Ribas - Director Grant or award Common Stock 5,700 $0.00 -
Jun 11, 2026 AR Antoni Ribas - Director Grant or award Stock Option (Right to Buy) 16,900 $0.00 -
Jun 11, 2026 AP Andrew J. Perlman - Director Grant or award Stock Option (Right to Buy) 16,900 $0.00 -
Jun 1, 2026 AA Alexander Azoy - Officer Open-market sale Common Stock 2,562 $25.77 $66K
Dec 16, 2025 AR Antoni Ribas - Director Gift Common Stock 5,050 $0.00 -
Jan 23, 2026 RM Richard Markus - Officer Grant or award Common Stock 24,000 $0.00 -
Jan 23, 2026 RM Richard Markus - Officer Grant or award Stock Option (right to buy) 96,000 $0.00 -
Jan 23, 2026 TR Terry J. Rosen - Officer Grant or award Common Stock 79,000 $0.00 -
Jan 23, 2026 TR Terry J. Rosen - Officer Grant or award Stock Option (right to buy) 315,000 $0.00 -
Jan 23, 2026 JJ Juan C. Jaen - Officer Grant or award Common Stock 31,000 $0.00 -
Jan 23, 2026 JJ Juan C. Jaen - Officer Grant or award Stock Option (right to buy) 126,000 $0.00 -
Jan 23, 2026 CT Carolyn C. Tang - Officer Grant or award Common Stock 24,000 $0.00 -
Jan 23, 2026 CT Carolyn C. Tang - Officer Grant or award Stock Option (right to buy) 96,000 $0.00 -
Jan 23, 2026 IG Ii Robert C. Goeltz - Officer Grant or award Stock Option (right to buy) 96,000 $0.00 -
Jan 23, 2026 AA Alexander Azoy - Officer Grant or award Common Stock 21,050 $0.00 -
Jan 23, 2026 AA Alexander Azoy - Officer Grant or award Stock Option (right to buy) 14,050 $0.00 -
Jan 23, 2026 JJ Jennifer Jarrett - Officer Grant or award Stock Option (right to buy) 126,000 $0.00 -
Dec 4, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 82,997 $24.71 $2.05M
Nov 26, 2025 AA Alexander Azoy - Officer Option exercise Common Stock 1,900 $13.33 $25K
Nov 26, 2025 AA Alexander Azoy - Officer Open-market sale Common Stock 1,900 $26.00 $49K
Nov 26, 2025 AA Alexander Azoy - Officer Option exercise Stock Option (right to buy) 1,900 $0.00 -
Nov 18, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 5,050 $19.75 $100K
Nov 17, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 37,114 $20.23 $751K
Nov 17, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 7,836 $20.71 $162K
Nov 7, 2025 JJ Jennifer Jarrett - Officer Option exercise Common Stock 50,291 $1.23 $62K
Nov 7, 2025 JJ Jennifer Jarrett - Officer Open-market sale Common Stock 50,291 $18.97 $954K
Nov 7, 2025 JJ Jennifer Jarrett - Officer Option exercise Stock Option (Right to Buy) 50,291 $1.23 $62K
Oct 30, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 4,314 $20.32 $88K
Oct 29, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 47,675 $20.49 $977K
Oct 29, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 29,365 $21.53 $632K
Oct 29, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 800 $22.04 $18K
Oct 28, 2025 JJ Juan C. Jaen - Officer Open-market sale Common Stock 19,019 $20.19 $384K
$RIGL
RIGEL PHARMACEUTICALS INC
$CORT
CORCEPT THERAPEUTICS INC
